United States · FDA National Drug Code directory

Guanfacine Extended-Release

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71205-946_6de48883-f40b-4aef-83d4-6acb86c1b11e
Product NDC
71205-946
Form
TABLET, EXTENDED RELEASE
Composition / generic term
Guanfacine
Labeler
Proficient Rx LP
Marketing category
ANDA
Marketing start / end (source format)
20170707
Source listing expiry
20261231

Source-listed ingredients

  • GUANFACINE — 3 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-946-00) · 71205-946-00
  • 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-946-30) · 71205-946-30
  • 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-946-55) · 71205-946-55
  • 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-946-60) · 71205-946-60
  • 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-946-90) · 71205-946-90

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →